Micah Mitchell Sells 48,000 Shares of Myomo, Inc. (NYSEAMERICAN:MYO) Stock

Myomo, Inc. (NYSEAMERICAN:MYO) insider Micah Mitchell sold 48,000 shares of the business’s stock in a transaction on Friday, March 14th. The shares were sold at an average price of $5.16, for a total value of $247,680.00. Following the completion of the sale, the insider now owns 140,572 shares in the company, valued at $725,351.52. This represents a 25.45 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Myomo Stock Up 2.4 %

MYO opened at $5.19 on Friday. Myomo, Inc. has a 12 month low of $2.51 and a 12 month high of $7.17. The firm has a market cap of $157.00 million, a P/E ratio of -22.57 and a beta of 1.68.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Soleus Capital Management L.P. purchased a new position in shares of Myomo in the 4th quarter valued at about $5,796,000. AIGH Capital Management LLC increased its holdings in shares of Myomo by 21.7% in the 4th quarter. AIGH Capital Management LLC now owns 3,381,567 shares of the company’s stock valued at $21,777,000 after acquiring an additional 602,719 shares during the last quarter. Portolan Capital Management LLC purchased a new position in shares of Myomo in the 4th quarter valued at about $2,446,000. Manatuck Hill Partners LLC purchased a new position in shares of Myomo in the 4th quarter valued at about $1,582,000. Finally, Aristides Capital LLC purchased a new position in shares of Myomo in the 4th quarter valued at about $1,288,000. 44.99% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

MYO has been the topic of several research analyst reports. HC Wainwright boosted their price objective on Myomo from $7.50 to $9.50 and gave the company a “buy” rating in a report on Wednesday. Alliance Global Partners reiterated a “buy” rating on shares of Myomo in a report on Tuesday. Finally, Craig Hallum boosted their price objective on Myomo from $9.00 to $11.00 and gave the company a “buy” rating in a report on Tuesday. Five investment analysts have rated the stock with a buy rating, According to MarketBeat, Myomo has an average rating of “Buy” and an average target price of $9.25.

Myomo Company Profile

Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living.